Bharat Biotech International Ltd on Wednesday said its oral Cholera Vaccine Hillchol has successfully completed phase III ...

Bharat Biotech International Ltd on Wednesday said its oral Cholera Vaccine Hillchol has successfully completed phase III clinical trials. The vaccine maker, in a press release, said it has ...

Successful track record in the commercialization of biopharmaceutical products as well as strategic advisory in orphan diseases ...

ReproNovo raises $65M for trials of leflutrozole and nolasiban in reproductive health. CEO Jean Marie Duvall plans Phase 2 ...

Bharat Biotech's Hillchol OCV, effective against cholera serotypes, aims to provide affordable, accessible vaccines for ...

Find out if gene therapy has also find its way into skin diseases. With two approvals in the last 2 years, is it the start of ...

KLANG: Duopharma Biotech Bhd has anticipated higher halal pharmaceuticals demand from Indonesia in the near term under its ...

A San Diego biotech company is helping top research labs develop mRNA vaccines, including a vaccine for some types of cancer. Jaime Chambers reports. STORY: fox5sandiego.com ...

More than 7 out of 10 South Korean biotech companies are facing financial difficulties, and nearly 4 in 10 have considered ...

In March, 23andMe said that it was looking to sell “substantially all of its assets” through a court-approved reorganization plan.

Prime Medicine, known for its goal of treating hundreds of diseases with CRISPR, says it's narrowing its focus to two. It ...

Durham-based Atsena Therapeutics has received Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration (FDA) for ATSN-201, its gene therapy product for the ...